Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation

Fig. 3

Sankey diagrams illustrating changes in migraine class from baseline to months 3 and 6: (A) Galcanezumab group; (B) OMPM group

Abbreviation: CM: chronic migraine; HFEM: high-frequency episodic migraine; LFEM: low-frequency episodic migraine; OMPM: oral migraine preventive medication; VLFEM: very low-frequency episodic migraine

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us